Profile
Raymund Breu served as Chief Financial Officer for Sandoz, Inc. from 1975 to 1990, Chief Financial Officer for Novartis AG from 1996 to 2009, and held various other financial positions at Sandoz and Novartis.
He also served as a Director or Non-Executive Director for several companies, including Swiss Re AG, Chiron Corp., and Nobel Biocare Holding AG.
Breu was a Member of the Management Board for SWX Group and served as Vice Chairman for the Swiss Takeover Board.
He holds a doctorate degree from the Swiss Federal Institute of Technology.
Former positions of Raymund Breu
| Companies | Position | End |
|---|---|---|
Swiss Takeover Board
Swiss Takeover Board General GovernmentGovernment Ensures rules and regulations of public takeover offers | Director/Board Member | 31/12/2013 |
| NOVARTIS AG | Director of Finance/CFO | 01/01/2009 |
SWX Group
SWX Group Investment Banks/BrokersFinance Operates a security and commodity exchange | Director/Board Member | 27/02/2008 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Director of Finance/CFO | 01/01/1996 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Director of Finance/CFO | 01/01/1990 |
Training of Raymund Breu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Schweizerische Rückversicherungs-Gesellschaft AG
Schweizerische Rückversicherungs-Gesellschaft AG Multi-Line InsuranceFinance Provides reinsurance, insurance and related risk transfer services | Finance |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
SWX Group
SWX Group Investment Banks/BrokersFinance Operates a security and commodity exchange | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Ltd.
Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets medicines | Health Technology |
Swiss Takeover Board
Swiss Takeover Board General GovernmentGovernment Ensures rules and regulations of public takeover offers | Government |
Sandoz Corp.
Sandoz Corp. Pharmaceuticals: MajorHealth Technology Developes, produces and markets medicines | Health Technology |
Swiss Re AG
Swiss Re AG Multi-Line InsuranceFinance Provides reinsurance services | Finance |
- Stock Market
- Insiders
- Raymund Breu
















